NewLink Genetics Corporation (NASDAQ:NLNK) said it entered into an agreement with Roche Holding AG to develop NewLink’s cancer immunotherapy, making the Ebola vaccine developer eligible to receive over $1 billion in milestone payments. NewLink Genetics Corporation (NASDAQ:NLNK) belongs to Healthcare sector. Its weekly performance is 58.04%. On last trading day company shares ended up $34.50. NewLink Genetics Corporation (NASDAQ:NLNK) distance from 50-day simple moving average … Continue reading NASDAQ Gainers: NewLink Genetics Corporation (NASDAQ:NLNK), ChinaNet Online Holdings, Inc. (NASDAQ:CNET), Canadian Solar Inc. (NASDAQ:CSIQ), On Track Innovations (NASDAQ:OTIV), Illumina Inc. (NASDAQ:ILMN)